Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'research area tgf tgf bcr abl'

Search results for: 'research area tgf tgf bcr abl'

Items 41-50 of 180

Page
per page
  1. DiscoveryProbe™ Anti-cancer Compound Library
    L1023 DiscoveryProbe™ Anti-cancer Compound Library
    Summary: 1164 anti-cancer compounds
  2. DiscoveryProbe™ Tyrosine Kinase Inhibitor Library
    L1028 DiscoveryProbe™ Tyrosine Kinase Inhibitor Library
    Summary: A unique collection of 369 tyrosine kinase inhibitors for high throughput screening (HTS) and high content screening (HCS).
  3. DiscoveryProbe™ Anti-cancer Compound Library Plus
    L1023P DiscoveryProbe™ Anti-cancer Compound Library Plus
    Summary: 2227 anti-cancer compounds
  4. DCC-2036 (Rebastinib)
    B1404 DCC-2036 (Rebastinib)
    Target: FLT3|Bcr-Abl|Tie-2|KDR
    Summary: Bcr-Abl inhibitor
      ≥27.7 mg/mL
  5. VX-680 (MK-0457,Tozasertib)
    A4111 VX-680 (MK-0457,Tozasertib)
    Target: Aurora Kinases
    Summary: Aurora kinase inhibitor
      ≥23.25 mg/mL
  6. Radotinib(IY-5511)
    B5846 Radotinib(IY-5511)
    Target: PDGFR|Bcr-Abl
    Summary: Bcr-Abl tyrosine kinase inhibitor
      ≥13.73 mg/mL
  7. Nilotinib monohydrochloride monohydrate
    A3660 Nilotinib monohydrochloride monohydrate
    Summary: Bcr-Abl inhibitor
      ≥50 mg/mL
  8. GNF-7
    B6033 GNF-7
    Summary: Type II Bcr-Abl inhibitor
      insoluble in EtOH; insoluble in H2O; ≥5.48 mg/mL
  9. Rocuronium Bromide
    A1366 Rocuronium Bromide
    Summary: TGF-βR I kinase inhibitor
      ≥30.48 mg/mL
  10. NSI-189
    B1150 NSI-189
    Summary: Nootropic and neurogenic research chemical
      Soluble in DMSO

Items 41-50 of 180

Page
per page